(Q35048251)

6 August 2017

1 reference

title

Public health measures in the control of viral hepatitis: a World Health Organization perspective for the next millennium (English)

1 reference

World Health Organization

6 August 2017

0 references

0 references

1 reference

1 reference

Daniel Lavanchy

1

1 reference

6 August 2017

1 December 2002

1 reference

Journal of Gastroenterology and Hepatology

6 August 2017

1 reference

6 August 2017

17 Suppl

1 reference

6 August 2017

S452-9

1 reference

History and epidemiology of hepatitis A virus

6 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S4.9.X

Epidemiology of hepatitis A in Mediterranean countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S4.9.X

Epidemiology of hepatitis A: seroepidemiology and risk groups in the USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S4.9.X

21 January 2018

Human viral hepatitis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S4.9.X

21 January 2018

The Viral Hepatitides

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S4.9.X

Epidemiology of hepatitis E virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S4.9.X

Experimental African HEV infection in cynomolgus macaques (Macaca fascicularis).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S4.9.X

Role of immune serum globulins in pregnant women during an epidemic of hepatitis E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S4.9.X

The transmission dynamics and control of hepatitis B virus in The Gambia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S4.9.X

Risk factors for hepatitis B virus infection among heterosexuals attending a sexually transmitted diseases clinic in Italy: role of genital ulcerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S4.9.X

Heterosexual transmission as the most common route of acute hepatitis B virus infection among adults in Taiwan--the importance of extending vaccination to susceptible adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S4.9.X

Inquiries on intraspousal transmission of hepatitis C virus: benefits and limitations of genome sequencing and phylogenetic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S4.9.X

Intrafamily transmission of hepatitis C virus: sexual and non-sexual contacts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S4.9.X

Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore--an analysis of 309 sex partnerships

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S4.9.X

Strategies to prevent and control hepatitis B and C virus infections: a global perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S4.9.X

Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S4.9.X

Treatment of chronic hepatitis B virus infection: an Asia-Pacific perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S4.9.X

Highly active antiretroviral therapy used to treat concurrent hepatitis B and human immunodeficiency virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S4.9.X

Hepatitis B virus variants with lamivudine-related mutations in the DNA polymerase and the 'a' epitope of the surface antigen are sensitive to ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S4.9.X

Combination alpha-interferon and lamivudine therapy for alpha-interferon-resistant chronic hepatitis B infection: results of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S4.9.X

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S4.9.X

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S4.9.X

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S4.9.X

Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S4.9.X

Treatment of hepatitis C: a decision that needs careful consideration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S4.9.X

A study on the role of the family and other risk factors in HCV transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S4.9.X

A controlled trial of interferon with or without prednisone priming for chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S4.9.X

Severe hepatitis E infection during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S4.9.X

Long-term efficacy of plasma-derived hepatitis B vaccine: a 15-year follow-up study among Chinese children

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S4.9.X

Hepatitis B vaccination and reduced risk of primary liver cancer among male adults: a cohort study in Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S4.9.X

Combination therapy with famciclovir and interferon-alpha for the treatment of chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S4.9.X

Prospective study of plasma fibronectin in fulminant hepatitis: association with infection and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S4.9.X

10.1046/J.1440-1746.17.S4.9.X

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12534777